Analytical Quality by Design Approach for a Stability-Indicating Method to Determine Apixaban and Its Related Impurities

被引:0
|
作者
Jéssica B. Ellwanger
Nathalie Ribeiro Wingert
Nadia Maria Volpato
Cássia Virginia Garcia
Elfrides E. S. Schapoval
Martin Steppe
机构
[1] Federal University of Rio Grande do Sul,Laboratory of Pharmaceutical Quality Control
来源
Chromatographia | 2020年 / 83卷
关键词
Apixaban; Quality-by-design; AQbD; Experimental design; Drug impurities;
D O I
暂无
中图分类号
学科分类号
摘要
Quality by Design (QbD) is a systematic approach that takes predefined objectives and emphasizes process understanding and control. Analytical QbD (AQbD) is widely used when it comes to the development and optimization of analytical methods. Since impurities and contaminants may be present in the pharmaceutical product, current regulatory guidelines recommend monitoring these substances. Thus, the aim of this work was to develop and validate a fast and sensitive stability indicating method by high-performance liquid chromatography (HPLC) for the simultaneous determination of apixaban and three synthesis impurities using AQbD approach. Experiments were designed and assessed on MODDE® 11 (Umetrics, Sweden) software and carried out in a Shimadzu® LC-20A Prominence HPLC–DAD at 220 nm. Design of experiments was applied to achieve the optimum conditions through response surface methodology with four quantitative critical method parameters (CMPs): column temperature, flow rate, mobile phase pH and organic percentage. Besides, the chromatographic column was the fifth CMP taken as a qualitative variable. The HPLC method was established using an Inertsil® CN-3 column at the temperature of 30 °C. The mobile phase consisted of methanol and water (50.2:49.8) at a flow rate of 1.015 mL/min with no pH adjustment. In order to confirm method selectivity excipients mixture was evaluated, as well as hydrolytic, photolytic, thermolytic, and oxidative conditions. The method was also validated for sensitivity (LOQ 0.5 μg/mL, LOD 0.01–0.05 μg/mL for impurities), linearity (concentration range 1–35 μg/mL for APX and 0.5–10 μg/mL for impurities, r > 0.999), precision (RSD ≤ 10%) and accuracy between levels (RSD < 3.0 for APX and < 4.0% for impurities). The application of AQbD led to a well-understood and validated analytical method that provided assured separation of APX and all significant impurities, turning it into a powerful decision-making tool for the analytical methodologies development.
引用
收藏
页码:65 / 75
页数:10
相关论文
共 50 条
  • [1] Analytical Quality by Design Approach for a Stability-Indicating Method to Determine Apixaban and Its Related Impurities
    Ellwanger, Jessica B.
    Wingert, Nathalie Ribeiro
    Volpato, Nadia Maria
    Garcia, Cassia Virginia
    Schapoval, Elfrides E. S.
    Steppe, Martin
    CHROMATOGRAPHIA, 2020, 83 (01) : 65 - 75
  • [2] Application of Quality by Design to optimize a stability-indicating LC method for the determination of ticagrelor and its impurities
    Wingert, Nathalie R.
    Ellwanger, Jessica B.
    Bueno, Livia M.
    Gobetti, Caren
    Garcia, Cassia V.
    Steppe, Martin
    Schapoval, Elfrides E. S.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 118 : 208 - 215
  • [3] Stability-indicating RP-HPLC method development and validation for determination of nine impurities in apixaban tablet dosage forms. Robustness study by quality by design approach
    Subramanian, Velusamy B.
    Katari, Naresh Kumar
    Dongala, Thirupathi
    Jonnalagadda, Sreekantha B.
    BIOMEDICAL CHROMATOGRAPHY, 2020, 34 (01)
  • [4] Quality by design with design of experiments approach for the development of a stability-indicating LC method for benzonatate and its impurities in liquid oral dosage form
    Katakam, Lakshmi Narasimha Rao
    Dongala, Thirupathi
    SEPARATION SCIENCE PLUS, 2020, 3 (07): : 276 - 285
  • [5] Quality by design with design of experiments approach for development of a stability-indicating LC method for enzalutamide and its impurities in soft gel dosage formulation
    Katakam, Lakshmi Narasimha Rao
    Dongala, Thirupathi
    Ettaboina, Santhosh Kumar
    BIOMEDICAL CHROMATOGRAPHY, 2021, 35 (05)
  • [6] Stability-indicating Analytical Method Development using Quality by Design Approach for Simultaneous Estimation of Ezetimibe and Glimepiride
    Shah, U.
    Shah, Kunti
    Patel, Rupal
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 81 (02) : 273 - 281
  • [7] Development and Validation of a Stability-Indicating Liquid Chromatographic Method with Mass-Spectrometric Detection for the Analysis of Apixaban and Determination of Production Related Impurities
    Basima Arous
    Mohammad Amer Al-Mardini
    Pharmaceutical Chemistry Journal, 2018, 52 : 573 - 581
  • [8] Development and Validation of a Stability-Indicating Liquid Chromatographic Method with Mass-Spectrometric Detection for the Analysis of Apixaban and Determination of Production Related Impurities
    Arous, Basima
    Al-Mardini, Mohammad Amer
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2018, 52 (06) : 573 - 581
  • [9] Analytical Quality By Design For Development Of A Sensitive, Rapid And Stability Indicating Method For Estimation Of Impurities Of Dimenhydrinate In Its Pharmaceutical Formulationl
    Girish, B. V.
    Praveen, S.
    Kathyayini, N.
    RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2016, 7 (04): : 1309 - 1322
  • [10] Development and Validation of a Stability-indicating RP-HPLC Method Using Quality by Design for Estimating Captopril
    Veerubhotla, K.
    Walker, R. B.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 81 (01) : 45 - 56